...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Isochaihulactone analogues: synthesis and anti-proliferative activity of novel dibenzylbutyrolactones.
【24h】

Isochaihulactone analogues: synthesis and anti-proliferative activity of novel dibenzylbutyrolactones.

机译:Isochaihulactone类似物:新型二苄基丁内酯的合成和抗增殖活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of dibenzyl-gamma-butyrolactones bearing a hydroxyl group at the benzylic position of 3-benzyl group were synthesized as hydrated analogue of isochaihulactone and evaluated against breast cancer human cell lines (MDA-M231, MCF-7 and T47D). The target compounds were synthesized in 7 steps from known lactone; (S)-(+)-gamma-benzyloxymethyl-gamma-butyrolactone. The key step was the aldol condensation between (+)-(R)-beta-(benzo[d][1,3]dioxol-5-ylmethyl)-gamma-butyrolactone and substituted benzaldehydes which afforded corresponding alpha-hydroxybenzyl butyrolactone analogues. The cytotoxic study of the synthesized compounds against breast cancer human cell lines showed that some of them inhibit breast cancer human cell proliferation with percentage inhibitions over 50% at concentrations less than 50 mug/mL.
机译:合成了一系列在3-苄基的苄基位置带有羟基的二苄基-γ-丁内酯作为异二十烷酸内酯的水合类似物,并针对乳腺癌人细胞系(MDA-M231,MCF-7和T47D)进行了评估。从已知的内酯分7步合成目标化合物。 (S)-(+)-γ-苄氧基甲基-γ-丁内酯。关键步骤是(+)-(R)-β-(苯并[d] [1,3]二恶酚-5-基甲基)-γ-丁内酯与取代的苯甲醛之间的醛醇缩合,得到相应的α-羟基苄基丁内酯类似物。合成化合物对乳腺癌人细胞系的细胞毒性研究表明,其中某些化合物在浓度低于50杯/毫升时可抑制乳腺癌人细胞的增殖,其抑制百分率超过50%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号